Condition | Indicated | Relationship Strength | Studies | Trials |
Hepatitis B Virus Infection [description not available] | 0 | 2.04 | 1 | 0 |
Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. | 0 | 7.04 | 1 | 0 |
Nasopharyngeal Carcinoma A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes. | 0 | 7.31 | 1 | 0 |
Cancer of Nasopharynx [description not available] | 0 | 2.31 | 1 | 0 |
Invasiveness, Neoplasm [description not available] | 0 | 2.66 | 2 | 0 |
Nasopharyngeal Neoplasms Tumors or cancer of the NASOPHARYNX. | 0 | 2.31 | 1 | 0 |
Anterior Choroidal Artery Infarction [description not available] | 0 | 2.6 | 1 | 0 |
Cerebral Ischemia [description not available] | 0 | 7.6 | 1 | 0 |
Cerebral Infarction The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction). | 0 | 2.6 | 1 | 0 |
Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. | 0 | 2.6 | 1 | 0 |
Breast Cancer [description not available] | 0 | 2.63 | 2 | 0 |
Breast Neoplasms Tumors or cancer of the human BREAST. | 0 | 2.63 | 2 | 0 |
Benign Neoplasms [description not available] | 0 | 2.17 | 1 | 0 |
Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. | 0 | 2.17 | 1 | 0 |
Hyperlipemia [description not available] | 0 | 2.17 | 1 | 0 |
Hyperlipidemias Conditions with excess LIPIDS in the blood. | 0 | 2.17 | 1 | 0 |
Fatty Liver, Nonalcoholic [description not available] | 0 | 2.21 | 1 | 0 |
Insulin Sensitivity [description not available] | 0 | 2.21 | 1 | 0 |
Diseases, Metabolic [description not available] | 0 | 2.21 | 1 | 0 |
Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. | 0 | 2.21 | 1 | 0 |
Metabolic Diseases Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed) | 0 | 2.21 | 1 | 0 |
Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY). | 0 | 7.21 | 1 | 0 |
Non-alcoholic Fatty Liver Disease Fatty liver finding without excessive ALCOHOL CONSUMPTION. | 0 | 2.21 | 1 | 0 |